Works by Park, Il Rae
Results: 9
Early glycaemic variability increases 28-day mortality and prolongs intensive care unit stay in critically ill patients with pneumonia.
- Published in:
- Annals of Medicine, 2022, v. 54, n. 1, p. 2724, doi. 10.1080/07853890.2022.2128399
- By:
- Publication type:
- Article
The Potential Role of Presepsin in Predicting Severe Infection in Patients with Diabetic Foot Ulcers.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2311, doi. 10.3390/jcm13082311
- By:
- Publication type:
- Article
Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.869451
- By:
- Publication type:
- Article
A Novel Index Using Soluble CD36 Is Associated with the Prevalence of Type 2 Diabetes Mellitus: Comparison Study with Triglyceride-Glucose Index.
- Published in:
- Endocrinology & Metabolism, 2017, v. 32, n. 3, p. 375, doi. 10.3803/EnM.2017.32.3.375
- By:
- Publication type:
- Article
Overcoming β-Cell Dysfunction in Type 2 Diabetes Mellitus: CD36 Inhibition and Antioxidant System.
- Published in:
- Diabetes & Metabolism Journal, 2025, v. 49, n. 1, p. 1, doi. 10.4093/dmj.2024.0796
- By:
- Publication type:
- Article
Does Rosuvastatin/Ezetimibe Combination Therapy Offer Potential Benefits for Glucose Metabolism beyond Lipid-Lowering Efficacy in T2DM?
- Published in:
- Diabetes & Metabolism Journal, 2024, v. 48, n. 3, p. 387, doi. 10.4093/dmj.2024.0168
- By:
- Publication type:
- Article
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study
- Published in:
- Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 818, doi. 10.4093/dmj.2023.0171
- By:
- Publication type:
- Article
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension
- Published in:
- Diabetes & Metabolism Journal, 2023, v. 47, n. 6, p. 808, doi. 10.4093/dmj.2022.0387
- By:
- Publication type:
- Article
Critical shear stress of red blood cells as a novel integrated biomarker for screening chronic kidney diseases in cases of type 2 diabetes.
- Published in:
- Clinical Hemorheology & Microcirculation, 2022, v. 81, n. 4, p. 293, doi. 10.3233/CH-211326
- By:
- Publication type:
- Article